Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplant

NCT05309382 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT05309382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplant
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
December 12, 2022
Completion date
October 2, 2024
Enrollment
147 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant